While progress has been made in characterizing humoral immunity to Zika virus (ZIKV) in
humans, little is known regarding the corresponding T cell responses to ZIKV. Here, we …

A monkey model of Zika virus (ZIKV) infection is urgently needed to better understand
transmission and pathogenesis, given its proven association with fetal brain defects in …

Zika virus (ZIKV) infection in pregnant women is a serious threat to the development and
viability of the fetus. The primary mode of ZIKV transmission to humans is through mosquito …

Following the 2015 Zika virus (ZIKV) outbreaks in the South Pacific, Caribbean, and
Americas, ZIKV has emerged as a serious threat due to its association with infantile …

The mosquito-borne Zika virus (ZIKV) has spread rapidly into regions where dengue virus
(DENV) is endemic, and flavivirus cross-reactive T cell responses have been observed …

Preexisting immunity against dengue virus or West Nile virus was previously reported to
mediate antibody-dependent enhancement (ADE) of Zika virus (ZIKV) infection in a mouse …

Immunodominant and highly conserved flavivirus envelope proteins can trigger cross-
reactive IgG antibodies against related flaviviruses, which shapes subsequent protection or …

Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are closely related to mosquito-
borne flaviviruses. Japanese encephalitis (JE) vaccine SA14-14-2 has been in the Chinese …

Zika virus (ZIKV), a mosquito-borne human pathogen, causes dire congenital brain
developmental abnormalities in children of infected mothers. The global health crisis …

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus with devastating outcomes seen
recently in the Americas due to the association of maternal ZIKV infection with fetal …